1-3 of 3
Vaibhav Agrawal, MD MBA
Close
Sort by
Journal Articles

A Multi-Institution Comparison of Mitoxantrone, Etoposide and Cytarabine (MEC) Vs High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Sonia Christian, MD, Pritesh Patel, MD, Vaibhav Agrawal, MD MBA, Shawn Griffin, PharmD, Kirk Cahill, MD, Irum Khan, MBBS, Karen Sweiss, PharmD, Ardaman Shergill, MD, Gregory Sampang Calip, PharmD,MPH,PhD, Wendy Stock, MD, Olatoyosi Odenike, MD, Heiko Konig, MDPhD, John G. Quigley
Journal: Blood
Blood (2018) 132 (Supplement 1): 1397.
https://doi.org/10.1182/blood-2018-99-111389
Published: 2018
Journal Articles

A Single Institution Comparison of Treatment Outcomes of Adolescent and Young Adult (AYA) Patients with Acute Myeloid Leukemia (AML) Treated in Pediatric and Adult Settings

Vaibhav Agrawal, MD MBA, Jordyn Griffin, MD, Andrew O'Brien, MD, Robert P. Nelson, Jr., MD, Jodi L. Skiles, MD, Heiko Konig, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5859.
https://doi.org/10.1182/blood-2018-99-114189
Published: 2018
Journal Articles

Efficacy of 90Y-Ibritumomab Tiuxetan in the Older Population with Non-Hodgkin Lymphoma Pre-Treated with Rituximab-Based Regimens: A Single-Institution Experience

Vaibhav Agrawal, MD MBA, Smelser T. Diane, PhD, Jose I. Castillo, MD, Kelly Raup, RN, Girton D. Treanna, RN, Scotty R. Collins, MD, James O. Brady, MD, Sharif S. Khan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4066.
https://doi.org/10.1182/blood.V130.Suppl_1.4066.4066
Published: 2017